Skip to main content

Table 2 Demographic features of patients with progressive supranuclear palsy and healthy control subjects

From: Multireceptor fingerprints in progressive supranuclear palsy

  Patients Control subjects p Value
n 16 14  
Age at death, years 72.5 (6.92)a 75.7 (10.07) 0.34
Male sex, n (%) 9 (56) 9 (64) 0.8
Disease duration, years 8.2 (2.26)a
Postmortem delay, h, mean (SD) 6.29 (1.21) 7.53 (1.31) 0.01
  1. aThree cases that underwent euthanasia were not included